SEARCH

SEARCH BY CITATION

References

  • Achenbach, T.M. (1991). Manual for the Child Behaviour Checklist – 4–18 and 1991 Profile. Burlington: University of Vermont.
  • American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th edn). Washington, DC: American Psychiatric Association.
  • Barkley, R.A. (1997). ADHD and the nature of self-control. New York: Guilford Press.
  • Barnett, R., Maruff, P., Vance, A., Luk, E.S.L., Costin, J., Wood, C. et al. (2001). Abnormal executive function in attention deficit hyperactivity disorder: The effect of stimulant medication and age on spatial working memory. Psychological Medicine, 31, 11071115.
  • Bedard, A.C., Ickowicz, A., & Tannock, R. (2002). Methylphenidate improves Stroop naming speed, but not response interference, in children with attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 12, 301309.
  • Bedard, A.C., Martinussen, R., Ickowicz, A., & Tannock, R. (2004). Methylphenidate improves visual-spatial memory in children with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 260268.
  • Berman, T., Douglas, V.I., & Barr, R.G. (1999). Effects of methylphenidate on complex cognitive processing in attention-deficit hyperactivity disorder. Journal of Abnormal Psychology, 108, 90105.
  • Broyd, S.J., Johnstone, S.J., Barry, R.J., Clarke, A.R., McCarthy, R., Selikowitz, M. et al. (2005). The effect of methylphenidate on response inhibition and the event-related potential of children with attention deficit/hyperactivity disorder. International Journal of Psychophysiology, 58, 4758.
  • Castellanos, F.X., & Tannock, R. (2002). Neuroscience of attention-deficit/hyperactivity disorder: The search for endophenotypes. Nature Reviews. Neuroscience, 3, 617628.
  • Coghill, D., Nigg, J., Rothenberger, A., Sonuga-Barke, E., & Tannock, R. (2005). Whither causal models in the neuroscience of ADHD? Developmental Science, 8, 105114.
  • Conners, C.K. (1997). Conners’ Rating Scales-Revised: Technical Manual. Toronto: MHS.
  • Curtis, W.J., Lindeke, L.L., Georgieff, M.K., & Nelson, C.A. (2002). Neurobehavioural functioning in neonatal intensive care unit graduates in late childhood and early adolescence. Brain, 125, 16461659.
  • Douglas, V.I. (1999). Cognitive control processes in attention-deficit/hyperactivity disorder. In H.C.Quay, & A.E.Hogan (Eds.), Handbook of disruptive behaviour disorders (pp. 105138). New York: Plenum Press.
  • Dunn, L., Dunn, L., Whetton, C., & Burley, J. (1997). British Picture Vocabulary Scale (2nd edn). London: NFER-Nelson.
  • Dyme, I.Z., Sahakian, B.J., Golinko, B.E., & Rabe, E.F. (1982). Perseveration induced by methylphenidate in children: Preliminary findings. Progress in Neuropsychopharmacology, Biology and Psychiatry, 6, 269273.
  • Elliott, R., Sahakian, B.J., Matthews, K., Bannerjea, A., Rimmer, J., & Robbins, T.W. (1997). Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology, 131, 196206.
  • Gao, W.J., & Goldman-Rakic, P.S. (2003). Selective modulation of excitatory and inhibitory microcircuits by dopamine. Proceedings of the National Academy of Science U.S.A., 100, 28362841.
  • Greenhill, L.L., Halperin, J.M., & Abikoff, H. (1999). Stimulant medications. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 503512.
  • Kaufman, J., Birmher, B., Brent, D., Rao, U., & Ryan, N. (1996). Kiddie-Sads Present and Lifetime Version (K-SADS-PL) Version 1.0. Pittsburgh: Department of Psychiatry, School of Medicine, University of Pittsburgh.
  • Kempton, S., Vance, A., Maruff, P., Luk, E., Costin, J., & Pantelis, C. (1999). Executive function and attention deficit hyperactivity disorder: Stimulant medication and better executive function performance in children. Psychological Medicine, 29, 527538.
  • Luciana, M. (2003). Practitioner review: Computerized assessment of neuropsychological function in children: Clinical and research applications of the Cambridge Neuropsychological Testing Automated Battery (CANTAB). Journal of Child Psychology and Psychiatry, 44, 649663.
  • Mehta, M.A., Goodyer, I.M., & Sahakian, B.J. (2004). Methylphenidate improves working memory and set-shifting in AD/HD: Relationships to baseline memory capacity. Journal of Child Psychology and Psychiatry, 45, 293305.
  • Mehta, M.A., Owen, A.M., Sahakian, B.J., Mavaddat, N., Pickard, J.D., & Robbins, T.W. (2000). Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. Journal of Neuroscience, 20, RC65.
  • Mehta, M.A., Sahakian, B.J., & Robbins, T.W. (2001). Comparative psychopharmacology of methylphenidate and related drugs in human volunteers, patients with ADHD and experimental animals. In M.V.Solanto, A.F.Arnsten, & F.X.Castellanos (Eds.), Stimulant drugs and ADHD: Basic and clinical neuroscience (pp. 303331). New York: Oxford University Press.
  • Milner, B. (1971). Interhemispheric differences in the localization of psychological processes in man. British Medical Bulletin, 27, 272277.
  • Petrides, M., & Milner, B. (1982). Deficits on subject-ordered tasks after frontal- and temporal-lobe lesions in man. Neuropsychologia, 20, 249262.
  • Rapport, M.D., & Kelly, K.L. (1991). Psycho-stimulant effects on learning and cognitive function: Findings and implications for children with attention deficit hyperactivity disorder. Clinical Psychology Review, 11, 6192.
  • Rhodes, S.M., Coghill, D.R., & Matthews, K. (2004). Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder. Psychopharmacology (Berlin), 175, 319330.
  • Rhodes, S.M., Coghill, D.R., & Matthews, K. (2005). Neuropsychological functioning in stimulant-naive boys with hyperkinetic disorder. Psychological Medicine, 35, 11091120.
  • Robbins, T.W., James, M., Owen, A.M., Sahakian, B.J., McInnes, L., & Rabbitt, P. (1994). Cambridge Neuropsychological Test Automated Battery (CANTAB): A factor analytic study of a large sample of normal elderly volunteers. Dementia, 5, 266281.
  • Robbins, T.W., & Sahakian, B.J. (1979). ‘Paradoxical’ effects of psychomotor stimulant drugs in hyperactive children from the standpoint of behavioural pharmacology. Neuropharmacology, 18, 931950.
  • Ross, R.G., Hommer, D., Breiger, D., Varley, C., & Radant, A. (1994). Eye movement task related to frontal lobe functioning in children with attention deficit disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 869874.
  • Safer, D.J., & Malever, M. (2000). Stimulant treatment in Maryland public schools. Pediatrics, 106, 533539.
  • Sahakian, B.J., & Owen, A.M. (1992). Computerized assessment in neuropsychiatry using CANTAB: Discussion paper. Journal of the Royal Society of Medicine, 85, 399402.
  • Scheres, A., Oosterlaan, J., Swanson, J., Morein-Zamir, S., Meiran, N., Schut, H. et al. (2003). The effect of methylphenidate on three forms of response inhibition in boys with AD/HD. Journal of Abnormal Child Psychology, 31, 105120.
  • Shallice, T. (1982). Specific impairments of planning. Philosophical Transactions of the Royal Society of London B, Biological Science, 298, 199209.
  • Shue, K.L., & Douglas, V.I. (1992). Attention deficit hyperactivity disorder and the frontal lobe syndrome. Brain and Cognition, 20, 104124.
  • Solanto, M.V. (1998). Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration. [Review] [290 refs]. Behavioural Brain Research, 94, 127152.
  • Sonuga-Barke, E.J. (2003). The dual pathway model of AD/HD: An elaboration of neuro-developmental characteristics. Neuroscience Biobehavioral Review, 27, 593604.
  • Toplak, M.E., Rucklidge, J.J., Hetherington, R., John, S.C., & Tannock, R. (2003). Time perception deficits in attention-deficit/hyperactivity disorder and comorbid reading difficulties in child and adolescent samples. Journal of Child Psychology and Psychiatry, 44, 888903.
  • Trommer, B.L., Hoeppner, J.A., & Zecker, S.G. (1991). The go-no go test in attention deficit disorder is sensitive to methylphenidate. Journal of Child Neurology, 6 (Suppl.), S12831.
  • Tukey, J.W. (1977). Exploratory data analysis. Reading, MA: Addison-Wesley.
  • Van der Meere, J., Gunning, B., & Stemerdink, N. (1999). The effect of methylphenidate and clonidine on response inhibition and state regulation in children with ADHD. Journal of Child Psychology and Psychiatry, 40, 291298.
  • Volkow, N.D., Wang, G., Fowler, J.S., Logan, J., Gerasimov, M., Maynard, L. et al. (2001). Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. Journal of Neuroscience, 21, RC121.
  • World Health Organisation. (1992). International Classification of Diseases (ICD-10). Geneva: WHO.